About
Pyrojas develops personalized autologous cancer vaccines by engineering whole tumor cell vaccines to activate a broad and durable immune response against heterogeneous cancer antigens.
Explore Pyrojas's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.